Sean Saint, CEO of Beta Bionics (BBNX), discusses the company’s IPO today and what the company does. Beta Bionics’ “bionic pancreas” is “the most automated” system to help control diabetes on the market, he says. He discusses why the system is better than regular insulin pumps, including its ability to learn and adapt, and how patients can access it.
Morning Trade Live
30 Jan 2025
SHARE